Werewolf Therapeutics, Inc.

NasdaqGS:HOWL

Market Cap

USD 61.48 M

Share Price

USD 1.37

Avg Daily Volume

504,261

Change (1 day)

-1.44%

Change (1 year)

-50.18%

Change (YTD)

-7.43%

Werewolf Therapeutics, Inc. Income Statement 2020 - 2025

This table shows the Income Statement for Werewolf Therapeutics, Inc. going from 2020 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.

Income Statement

Annual data in millions of USD, except per share data Trend